Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Profit After Tax: 2012-2024

Historic Profit After Tax for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to -$409.2 million.

  • Ascendis Pharma A's Profit After Tax rose 34.55% to -$71.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$255.9 million, marking a year-over-year increase of 44.67%. This contributed to the annual value of -$409.2 million for FY2024, which is 21.00% up from last year.
  • According to the latest figures from FY2024, Ascendis Pharma A's Profit After Tax is -$409.2 million, which was up 21.00% from -$518.0 million recorded in FY2023.
  • In the past 5 years, Ascendis Pharma A's Profit After Tax registered a high of -$409.2 million during FY2024, and its lowest value of -$595.0 million during FY2022.
  • In the last 3 years, Ascendis Pharma A's Profit After Tax had a median value of -$518.0 million in 2023 and averaged -$507.4 million.
  • In the last 5 years, Ascendis Pharma A's Profit After Tax slumped by 95.92% in 2020 and then climbed by 21.00% in 2024.
  • Yearly analysis of 5 years shows Ascendis Pharma A's Profit After Tax stood at -$478.4 million in 2020, then rose by 8.27% to -$438.8 million in 2021, then slumped by 35.60% to -$595.0 million in 2022, then increased by 12.94% to -$518.0 million in 2023, then rose by 21.00% to -$409.2 million in 2024.